Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
Gerd-Rüdiger R BurmesterVibeke StrandAlan J KivitzChih-Chi HuSheldon WangHubert van HoogstratenGabriella L KlierRoy FleischmannPublished in: Rheumatology (Oxford, England) (2023)
EXTEND, ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT01146652, NCT01146652; MONARCH OLE, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT02332590, NCT02332590.
Keyphrases